Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $382M (up 7.5% year over year) with net income of $41M.
Q1 2026 key financials · XBRL
- Revenue
- $382M
- +7.5% YoY
- Net income
- $41M
- +36.0% YoY
- Operating margin
- 11.6%
- Gross margin
- 48.4%
- EPS (diluted)
- $0.68
- +38.8% YoY
Source: XBRL data from the MERIT MEDICAL SYSTEMS INC (MMSI) Q1 2026 10-Q on SEC EDGAR. USD.
MERIT MEDICAL SYSTEMS INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $381.9M, up 7.5% YoY from $355.4M
- Net margin 10.7% vs 8.5%; operating margin 11.6% vs 11.5%
- Best segment therapeutic sales $126.4M, up 9.9%; foundational sales $255.5M, up 6.3%
- Cash $490.2M vs $448.5M; operating cash flow $40.7M vs $40.6M
- 2026 capital spending outlook $80–$100M; tariff recovery uncertainty and vendor supply delays as headwinds
Risk Factors
- Newly added geopolitical risk triggered by February 2026 U.S.-Israel strikes against Iran and retaliatory missile attacks
- Most material update: conflict escalation threatens global energy supplies and petroleum-based input costs, including resins
- Regulatory and compliance exposure from potential sanctions and government responses disrupting trade and transportation routes
- Near-term operational risk from adverse effects on global supply chains, customer spending, and regional transportation
- Financial market exposure through potential currency exchange-rate, interest-rate, and broader financial-market volatility
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MERIT MEDICAL SYSTEMS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.